Nicoleta Cristina Olarescu
- Consultant; MD, PhD
Publications 2024
PCSK1N as a tumor size marker and an ER stress response protein in corticotroph pituitary adenomas
J Clin Endocrinol Metab (in press)
DOI 10.1210/clinem/dgae643, PubMed 39288010
Long-term depot specific changes in adipose tissue after treatment of acromegaly
Eur J Endocrinol, 190 (3), K37-K42
DOI 10.1093/ejendo/lvae016, PubMed 38401530
Stem cell-associated transcription factors in non-functioning pituitary neuroendocrine tumours
Free Neuropathol, 5
DOI 10.17879/freeneuropathology-2024-5396, PubMed 38845811
Publications 2023
Gene expression profiling of subcutaneous adipose tissue reveals new biomarkers in acromegaly
Eur J Endocrinol, 188 (3)
DOI 10.1093/ejendo/lvad031, PubMed 36895180
Long-term control of acromegaly after pituitary surgery in South-Eastern Norway
Acta Neurochir (Wien), 165 (10), 3003-3010
DOI 10.1007/s00701-023-05772-7, PubMed 37665404
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours
Pituitary, 26 (2), 227-236
DOI 10.1007/s11102-023-01310-x, PubMed 36952069
Adipokine profile in long-term juvenile dermatomyositis, and associations with adipose tissue distribution and cardiac function: a cross-sectional study
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002815, PubMed 36828644
Publications 2022
Trends in incidence and mortality risk for acromegaly in Norway: a cohort study
Endocrine, 80 (1), 152-159
DOI 10.1007/s12020-022-03275-6, PubMed 36525222
Publications 2020
Distinct Pattern of Endoplasmic Reticulum Protein Processing and Extracellular Matrix Proteins in Functioning and Silent Corticotroph Pituitary Adenomas
Cancers (Basel), 12 (10)
DOI 10.3390/cancers12102980, PubMed 33066652
Diagnosis and Treatment of Parasellar Lesions
Neuroendocrinology, 110 (9-10), 728-739
DOI 10.1159/000506905, PubMed 32126547
FSH Levels Are Related to E-cadherin Expression and Subcellular Location in Nonfunctioning Pituitary Tumors
J Clin Endocrinol Metab, 105 (8), 2587-94
DOI 10.1210/clinem/dgaa281, PubMed 32421791
TGFBR3L-An Uncharacterised Pituitary Specific Membrane Protein Detected in the Gonadotroph Cells in Non-Neoplastic and Tumour Tissue
Cancers (Basel), 13 (1)
DOI 10.3390/cancers13010114, PubMed 33396509
Publications 2019
MANAGEMENT OF ENDOCRINE DISEASE: Individualised management of acromegaly
Eur J Endocrinol, 181 (2), R57-R71
DOI 10.1530/EJE-19-0124, PubMed 31100716
Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study
JBMR Plus, 3 (12), e10240
DOI 10.1002/jbm4.10240, PubMed 31844828
Aggressive and Malignant Prolactinomas
Neuroendocrinology, 109 (1), 57-69
DOI 10.1159/000497205, PubMed 30677777
Publications 2017
Gene expression profiling of fast- and slow-growing non-functioning gonadotroph pituitary adenomas
Eur J Endocrinol, 178 (3), 295-307
DOI 10.1530/EJE-17-0702, PubMed 29259037
Publications 2016
Treatment of acromegaly increases BMD but reduces trabecular bone score: a longitudinal study
Eur J Endocrinol, 175 (2), 155-64
DOI 10.1530/EJE-16-0340, PubMed 27220351
Selection and validation of reliable reference genes for RT-qPCR analysis in a large cohort of pituitary adenomas
Mol Cell Endocrinol, 437, 183-189
DOI 10.1016/j.mce.2016.08.030, PubMed 27561203
The Impact of Adipose Tissue on Insulin Resistance in Acromegaly
Trends Endocrinol Metab, 27 (4), 226-237
DOI 10.1016/j.tem.2016.02.005, PubMed 26948712
Publications 2015
GH action influences adipogenesis of mouse adipose tissue-derived mesenchymal stem cells
J Endocrinol, 226 (1), 13-23
DOI 10.1530/JOE-15-0012, PubMed 25943560
The Metabolic Risk in Patients Newly Diagnosed with Acromegaly Is Related to Fat Distribution and Circulating Adipokines and Improves after Treatment
Neuroendocrinology, 103 (3-4), 197-206
DOI 10.1159/000371818, PubMed 25592241
Publications 2014
Dual-energy X-ray absorptiometry is a valid method to estimate visceral adipose tissue in adult patients with Prader-Willi syndrome during treatment with growth hormone
J Clin Endocrinol Metab, 99 (9), E1727-31
DOI 10.1210/jc.2014-2059, PubMed 24955611
Increased serum and bone matrix levels of the secreted Wnt antagonist DKK-1 in patients with growth hormone deficiency in response to growth hormone treatment
J Clin Endocrinol Metab, 100 (2), 736-43
DOI 10.1210/jc.2014-2912, PubMed 25459913
Publications 2013
Inflammatory adipokines contribute to insulin resistance in active acromegaly and respond differently to different treatment modalities
Eur J Endocrinol, 170 (1), 39-48
DOI 10.1530/EJE-13-0523, PubMed 24092547
Publications 2012
Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly
J Clin Endocrinol Metab, 97 (4), 1355-62
DOI 10.1210/jc.2011-2417, PubMed 22319029
Publications 2011
Increased serum and bone matrix levels of transforming growth factor {beta}1 in patients with GH deficiency in response to GH treatment
Eur J Endocrinol, 165 (3), 393-400
DOI 10.1530/EJE-11-0442, PubMed 21653735